Form D · Biotechnology
Silence Therapeutics plc
London, X0 · CIK 0001479615
Offering snapshot reported Feb 18, 2021 · SEC filing
- Reported sold
- $45.5M Offering amount: $45.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 4, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 18, 2021 | Initial | $45,499,905 | No comparison | 12 | SEC filing |
| Jan 5, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 5, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 5, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.73M
- Finders' fees
- $0
- Form D file number
- 021-389800
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| William Blair & Company, L.L.C. | 1252 |
Source: Form D, filed Feb 18, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Giles Campion | Executive |
| Annette Clancy | Director |
| Jeremy Curnock Cook | Director |
| Michael H. Davidson | Director |
| Melvyn Davies | Director, Executive |
| James Ede Golightly | Director |
| Alistair Gray | Director |
| Dave Lemus | Director |
| Jerry Randall | Director |
| Peter Reynolds | Director |
| Iain Ross | Director |
| Mark Rothera | Director, Executive |
| Barbara Ruskin | Executive |
| Romano Steven | Director |
| Craig Tooman | Executive |
| David U'prichard | Director |
| Bernd Wetzel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
72 Hammersmith Road
London, X0, W14 8TH
London, X0, W14 8TH